Treatment of dyslipidemia in patients with diabetes mellitus.
Journal Title: Pharmacological Reports - Year 2005, Vol 57, Issue
Abstract
The article reviews the key aspects of pathophysiology of diabetic dyslipidemia, its treatment and associated risk of cardiovascular complications. It examines the difference in lipidmetabolism between type 1 and type 2 diabetes mellitus. The diagnostic values of particular lipid abnormalitiesas risk predictors for cardiovascular events are analyzed. Guidelines on hypolipemic treatment in diabetes are summarized and commented on. Standard and newly introduced methods as well as new opportunities of hypolipemic treatment are presented.
Authors and Affiliations
Witold Pikto-Pietkiewicz, Katarzyna Wołkowska, Tomasz Pasierski
Keywords
Related Articles
- EP ID EP144322
- DOI -
- Views 131
- Downloads 0
Impact of hypercholesterolemia on toxicity of N-nitrosodiethylamine: biochemical and histopathological effects.
N-nitrosodiethylamine (NDEA) is an important carcinogen frequently present in human environment and food chain. Nitrosamines such as NDEA produce oxidative stress due to generation of reactive oxygen species and alter th...
Hydrogen sulfide (H(2)S) - the third gas of interest for pharmacologists.
Nitric oxide (NO) and carbon monoxide (CO) synthesized from L-arginine by NO synthase and from heme by heme oxygenase, respectively, are the well-known neurotransmitters and are also involved in the regulation of vascula...
Granulocyte colony-stimulating factor improves early remodeling in isoproterenol-induced cardiac injury in rats.
Background: Granulocyte colony-stimulating factor (G-CSF) has been used in some animal models and humans with well-established cardiovascular diseases. However, its effects in the initial stage of progressive non-ischemi...
Neurochemical modulation of stress-induced cognitive inflexibility in a rat model of an attentional set-shifting task.
It is widely accepted that chronic stress, which is considered a risk factor for several neuropsychiatric disorders, may have detrimental effects on prefrontal functions. In animal models, chronic stress produces morphol...
Induction of caspase 3 activity, bcl-2 bax and p65 gene expression modulationin human acute promyelocytic leukemia HL-60 cells by doxorubicin with amifostine.
The influence of amifostine alone and in combination with doxorubicin,cytarabine, and etoposide on the cell growth and on bcl-2, bax and p65 gene expression was investigatedin human acute promyelocytic leukemia cell line...